<DOC>
	<DOCNO>NCT02997059</DOCNO>
	<brief_summary>This prospective study randomize two control parallel group verum versus placebo . The objective assess influence antifungal treatment Fluconazole ( FCZ ) rate ASCA endoscopic recurrence 6 month . The rational base previous research establish ) link intestinal inflammation opportunistic fungal pathogen C. albicans -a yeast colonize human digestive tract- ii ) demonstration yeast specie could origin ASCA , prominent serological marker CD . It therefore hypothesize FCZ could lower rate ASCA and/or reduce occurrence recurrence .</brief_summary>
	<brief_title>Effect Fluconazole Levels ASCA After Surgical Resection Crohn 's Disease .</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<criteria>1 . Crohn disease patient small intestine localisation ( ileum ileocecal ) 2 . Ileal ileocecal resection month inclusion ( resection macroscopic lesion ) . If resection temporary stoma , patient may include time surgery restore continuity 3 . Patient low risk recurrence accord follow criterion : ( ) Total length resection ( ) small intestine le 100 cm ( ii ) Segmental colectomy leave place least another colonic segment rectum 4 . Preoperative rate ASCA &gt; 70 arbitrary unit ( +/ 10 % ) 5 . Informed consent sign involve study 1 . Pregnant woman without adequate contraception 2 . Total length resection ( ) small intestine 1 meter 3 . Subtotal colic resection 4 . Preoperative rate ASCA &lt; 63 arbitrary unit ( +/ 10 % ) 5 . Known hypersensitivity fluconazole azoles 6 . Known liver disease transaminase level &gt; 1.5 normal rate 7 . Patient renal failure 8 . Inability read sign inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Crohn disease</keyword>
	<keyword>Candida</keyword>
	<keyword>ASCA</keyword>
</DOC>